Elligo Health Research on Thursday announced its acquisition of ePatientFinder’s Clinical Trial Exchange technology platform and practice network.
According to a press release, the platform will bolster Elligo’s trial matching process, allowing it to “streamline patient identification and feasibility” by using data pulled from electronic health records.
“We believe this is an important strategic opportunity for Elligo to expand our technology and network growth capabilities,” Elligo CEO John Potthoff said. “ePatientFinder provides a technology platform and partnership ecosystem that will enable us to automate our EHR data analytics capabilities and expand our network of Research Ready sites to further benefit physicians, patients and sponsors.”
To read more about the acquisition, click here.